The only thing that will matter is OS data 2nd half of year, and any other updates. Good run up but I would not chase it after this run up. Buy back under 3.60-3.80.
Really? Can you point to the original source of this old news then? Please tell me where I can find the previously released 6 month PFS for 1st line STS.
you may get a pullback, but that would be a buying opp ..
aldo is safer .. also, more patients with aldo had tumor get smaller than patients with dox